by Asa Elmore | Sep 21, 2020 | Events, News, Press Releases
Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC SOUTH SAN FRANCISCO, Calif., Sept. 21, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company today announced that it has been...
by Asa Elmore | Sep 17, 2020 | Events, Presentations
Sutro Biopharma Presents at World ADC 2020 – PowerPoint Presentation To download the World ADC presentation by Arturo Molina, MD, MS, Chief Medical Officer, CLICK HERE To download the World ADC presentation by Trevor Hallam, Ph.D., Chief Scientific Officer,...
by Asa Elmore | Sep 15, 2020 | Events, Presentations
Cantor Fitzgerald Virtual Heathcare Conference 2020 – PowerPoint Presentation To download the presentation, Click...
by Asa Elmore | Sep 11, 2020 | News
STRO-002 Shows Early Efficacy, Safety in Heavily Pretreated Epithelial Ovarian Cancer – OncLive September 2020 The novel anti-folate receptor alpha antibody-drug conjugate STRO-002 demonstrated encouraging efficacy with a tolerable safety profile in patients...
by Asa Elmore | Sep 9, 2020 | News, Presentations
International Gynecologic Cancer Society (IGCS) Virtual Healthcare Conference 2020 – Poster Phase 1 Dose-Escalation Study of STRO-002, An Anti-Folate Receptor Alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum-Resistant/Refractory...
by Asa Elmore | Sep 9, 2020 | News, Presentations
Investor Conference Call September 9, 2020 – Presentation To download the presentation, Click...
